APO-LENALIDOMIDE
Identification of Apo-Lenalidomide
No description |
Google image searchProduct monograph
Active ingredient
lenalidomide, 15 MG
DIN: 02507951
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: APOTEX INC
Date: 01-SEP-2021
ATC:
- L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
- L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
- L04AX — Other immunosuppressants (ATC, ATC/DDD)
- L04AX04 — LENALIDOMIDE (ATC/DDD)
Reference brand drug: Revlimid
Pharmaceutical standard: MFR
External Links for Apo-Lenalidomide
Search on Google
Apotex Inc
Go to Apotex website to see drug product details. Sometimes you can find apo-lenalidomide photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.